Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Florence Blais"'
Autor:
Normand Blais, Wiam Belkaid, Andréanne Gagné, Philippe Joubert, Michèle Orain, Julie Malo, Florence Blais, Corentin Richard, Xavier Deschênes-Simard, François Ghiringhelli, Loïck Galland, Bertrand Routy, Lena Cvetkovic, Arielle Elkrief, Antoine Desilets, Marc-André Hamel
Publikováno v:
Thrombosis Research. 205:29-39
Venous thrombotic events (VTEs) are a frequent complication of non-small cell lung cancer (NSCLC) and are associated with increased morbidity. Immune checkpoint inhibitors (ICIs) are revolutionizing the management of NSCLC, but little is known about
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d39acc49ab26458fae9269551a02c57e
https://doi.org/10.1016/j.thromres.2021.06.018
https://doi.org/10.1016/j.thromres.2021.06.018
Autor:
Sara-Maude Desforges, Olena Bereznyakova, Christian Stapf, Gregory Jacquin, Valerie Fraile, Jade Bergeron, Amer Yassine Hafsaoui, Florence Blais, Mathias Castonguay, Mireille Fortier-St-Pierre, Kevin H.M. Kuo, Denis Soulières, Stephanie Forte
Publikováno v:
Blood. 140:5144-5145
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea79a36da9c65413160e9d2e85fc55b1
https://doi.org/10.1182/blood-2022-170134
https://doi.org/10.1182/blood-2022-170134
Autor:
Michèle Orain, Lena Cvetkovic, Marc-André Hamel, Andréanne Gagné, Florence Blais, Normand Blais, Philippe Joubert, Wiam Belkaid, Bertrand Routy, François Ghiringhelli, Antoine Desilets, Julie Malo, Xavier Deschênes-Simard, Arielle Elkrief, Loik Galland
Publikováno v:
Journal of Clinical Oncology. 39:e21198-e21198
e21198 Background: Venous thromboembolism is a frequent complication of non-small cell lung cancer (NSCLC) and is associated with a worse prognosis, a reduced quality of life, and increased healthcare costs. Immune checkpoint inhibitors (ICI) are rev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed51d9042d33cb46e6783378543f53de
https://doi.org/10.1200/jco.2021.39.15_suppl.e21198
https://doi.org/10.1200/jco.2021.39.15_suppl.e21198
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nafanta Fadiga, Stéphanie Forté, Béland Sébastien, Mathias Castonguay, Melanie Cohn, Denis Soulières, Florence Blais, Kevin H.M. Kuo, Richard Ward
Publikováno v:
Blood. 134:2294-2294
Background: Sickle cell disease (SCD) patients are at significant risk for stroke and silent cerebral infarcts. At least 33% of adults have cognitive dysfunction. However, access to specialized assessments is limited, and there is currently an unmet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bd920c27d4024051834a1907f1dfaf8
https://doi.org/10.1182/blood-2019-129342
https://doi.org/10.1182/blood-2019-129342